ArticleEJIFCC2021

Avoiding insufficient therapies and overdosing with co-reporting eGFRs (estimated glomerular filtration rate) for personalized drug therapy and improved outcomes - a simulation of the financial benefits.

Adrian Hoenle et al.PubMed ↗Full text ↗

No numbers read from the abstract.